HOME >> MEDICINE >> NEWS
ESC highlights need for screening and global risk management as statins move over the counter in UK

Today Dr John Reid, the Health Secretary for the United Kingdom (UK), announced the reclassification of statins as 'over the counter' products in the UK, to be available to members of the public directly from pharmacists without the need for a prescription. With this move, recently approved by the UK's Committee on Safety of Medicines, the UK is the first country to move a statin from prescription-only to over the counter access.

The initial statin to be available from pharmacists will be simvastatin, at a daily dosage of 10mg. Simvastatin will be targeted at individuals with a low to moderate risk of heart disease, specifically sub-populations such as men aged 50 years and over and women aged 55 and over with one or more risk factors including: obesity, cigarette smoking, insufficient physical exercise, unhealthy diet, hypertension, diabetes or family history of heart disease. An on-the-spot blood test is envisaged to assess if an individual requesting simvastatin is eligible and if the results are positive the treatment can be purchased immediately.

As a result of this decision, UK health authorities expect to increase the usage of statins in primary prevention, in order to reduce cholesterol levels in the UK population and ultimately reduce the country's high incidence of heart disease, arguing that the move is in favour of improving patient choice and access to medicines.

Statins not a stand-alone prevention measure

In light of this development, the European Society of Cardiology (ESC) stresses the importance of viewing statins appropriately within the global risk management environment.

Simvastatin, along with the other statins in its class, is a very effective treatment option in both primary and secondary cardiovascular disease prevention. However, it is by no means a substitute for lifestyle factor improvements and should only be taken in parallel to effective risk factor reduction methods such as health
'"/>

Contact: Camilla Dormer
cdormer@escardio.org
33-49-294-8627
European Society of Cardiology
12-May-2004


Page: 1 2 3

Related medicine news :

1. Other highlights in the March 16 JNCI
2. Other highlights in the March 2 JNCI
3. Other highlights in the February 2 JNCI
4. Article highlights confusion about Homeland Security safety symbols
5. Other highlights in the January 19 JNCI
6. US study highlights clear link between increased fast-food consumption and obesity
7. Other highlights in the December 15 JNCI
8. European study highlights persistent 3 decade increase in childhood cancer incidence
9. Other highlights in the December 1 JNCI
10. Ugandan study highlights best drug combinations for treating malaria in Africa
11. Study highlights importance of pesticide worker dermal exposure

Post Your Comments:
(Date:2/28/2015)... The MCA Youth Empowerment Conference aims to ... and gears towards the goal for a better future ... talks in smaller groups will be held after the ... Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women and Youth ... , Young adults aged between 18-30 years ...
(Date:2/28/2015)... In a recent episode of SCI TV ... Athlete Development Services and Consultancy talks with Joshua ... development and player engagement during and after their careers. ... face and how off-field activities are a critical component ... in athlete development issues while in graduate school coaching ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The Heart ... now a distributor of the machine. The Heart Fit ... their license, like a franchise model. The goal is ... and reverse heart disease. To buy External Counterpulsation ... Clinic can help individuals through this process and achieve ...
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax ... business consulting services in addition to a variety of ... succession planning. Company finances are a complicated matter that ... of this, complex Canadian tax laws can make it ... result, Mew and Company works to advise their clients ...
(Date:2/28/2015)... CA (PRWEB) February 28, 2015 A ... a promising new gene therapy procedure for the treatment ... blindness in patients. Authored by Dr. Robert ... and published in the Lancet Medical Journal on January ... from choroideremia, a rare genetic disorder that mostly affects ...
Breaking Medicine News(10 mins):Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2
(Date:2/27/2015)... Roughly three-quarters of pharmacists said they ... interchangeable biosimilar for its branded biologic counterpart if ... according to a survey published in the Academy ... Managed Care & Specialty Pharmacy (JMCP). ... would feel as confident if the products had ...
(Date:2/27/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a leading open-access ... biotechnology, and medical device industries with operations in ... States , congratulates our partner TaiMed Biologics for ... ibalizumab (TMB355). The FDA designates a drug as a ... combination with one or more other drugs, to treat ...
(Date:2/27/2015)... Feb. 27, 2015  Acsis Inc., the market leader ... announced today that John DiPalo , Acsis, Chief ... & Demand Chain Executive 2015 Provider Pro to ... leading initiatives to help prepare their companies, and customers, ... climate. This year,s list of Provider Pros to Know ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2
Cached News: